<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>http://70.231.62.181/index.php?action=history&amp;feed=atom&amp;title=Sabeluzole</id>
	<title>Sabeluzole - Revision history</title>
	<link rel="self" type="application/atom+xml" href="http://70.231.62.181/index.php?action=history&amp;feed=atom&amp;title=Sabeluzole"/>
	<link rel="alternate" type="text/html" href="http://70.231.62.181/index.php?title=Sabeluzole&amp;action=history"/>
	<updated>2026-04-23T23:01:50Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.45.1</generator>
	<entry>
		<id>http://70.231.62.181/index.php?title=Sabeluzole&amp;diff=8616796&amp;oldid=prev</id>
		<title>imported&gt;JWBE: removed Category:Fluoroarenes; added Category:4-Fluorophenyl compounds using HotCat</title>
		<link rel="alternate" type="text/html" href="http://70.231.62.181/index.php?title=Sabeluzole&amp;diff=8616796&amp;oldid=prev"/>
		<updated>2024-09-07T15:19:02Z</updated>

		<summary type="html">&lt;p&gt;removed &lt;a href=&quot;/index.php/Category:Fluoroarenes&quot; title=&quot;Category:Fluoroarenes&quot;&gt;Category:Fluoroarenes&lt;/a&gt;; added &lt;a href=&quot;/index.php/Category:4-Fluorophenyl_compounds&quot; title=&quot;Category:4-Fluorophenyl compounds&quot;&gt;Category:4-Fluorophenyl compounds&lt;/a&gt; using &lt;a href=&quot;/index.php?title=WP:HC&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;WP:HC (page does not exist)&quot;&gt;HotCat&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{Short description|Chemical compound}}&lt;br /&gt;
{{Drugbox&lt;br /&gt;
| verifiedrevid = 451729293&lt;br /&gt;
| IUPAC_name = 1-[4-[1,3-benzothiazol-2-yl(methyl)amino]piperidin-1-yl]-3-(4-fluorophenoxy)propan-2-ol&lt;br /&gt;
| image = Sabeluzole.svg&lt;br /&gt;
| width = 260&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Clinical data--&amp;gt;&lt;br /&gt;
| tradename =  &lt;br /&gt;
| pregnancy_category =  &lt;br /&gt;
| legal_status = Unscheduled&lt;br /&gt;
| routes_of_administration =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Pharmacokinetic data--&amp;gt;&lt;br /&gt;
| bioavailability =  &lt;br /&gt;
| metabolism =  &lt;br /&gt;
| excretion =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Identifiers--&amp;gt;&lt;br /&gt;
| CAS_number = 104383-17-7&lt;br /&gt;
| ATC_prefix = none&lt;br /&gt;
| PubChem = 59823&lt;br /&gt;
| ChemSpiderID      = 53964&lt;br /&gt;
| StdInChI          = 1S/C22H26FN3O2S/c1-25(22-24-20-4-2-3-5-21(20)29-22)17-10-12-26(13-11-17)14-18(27)15-28-19-8-6-16(23)7-9-19/h2-9,17-18,27H,10-15H2,1H3&lt;br /&gt;
| StdInChIKey       = IGMKTIJBFUMVIN-UHFFFAOYSA-N&lt;br /&gt;
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}&lt;br /&gt;
| UNII_Ref = {{fdacite|correct|FDA}}&lt;br /&gt;
| UNII = A998504XY4&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Chemical data--&amp;gt;&lt;br /&gt;
| C=22 | H=26 | F=1 | N=3 | O=2 | S=1 &lt;br /&gt;
| smiles = CN(C1CCN(CC1)CC(COC2=CC=C(C=C2)F)O)C3=NC4=CC=CC=C4S3&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Sabeluzole&amp;#039;&amp;#039;&amp;#039; (&amp;#039;&amp;#039;&amp;#039;R-58,735&amp;#039;&amp;#039;&amp;#039;) is a [[nootropic]] and [[neuroprotective]] drug which was originally developed for the treatment of [[Alzheimer&amp;#039;s disease]],&amp;lt;ref name=&amp;quot;pmid3126527&amp;quot;&amp;gt;{{cite journal | vauthors = Clincke GH, Tritsmans L, Idzikowski C, Amery WK, Janssen PA | title = The effect of R 58 735 (Sabeluzole) on memory functions in healthy elderly volunteers | journal = Psychopharmacology | volume = 94 | issue = 1 | pages = 52–7 | year = 1988 | pmid = 3126527 | doi = 10.1007/BF00735880 | s2cid = 28451054 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid9260731&amp;quot;&amp;gt;{{cite journal | vauthors = Mohr E, Nair NP, Sampson M, Murtha S, Belanger G, Pappas B, Mendis T | title = Treatment of Alzheimer&amp;#039;s disease with sabeluzole: functional and structural correlates | journal = Clinical Neuropharmacology | volume = 20 | issue = 4 | pages = 338–45 | date = August 1997 | pmid = 9260731 | doi = 10.1097/00002826-199708000-00005 }}&amp;lt;/ref&amp;gt; and has subsequently been researched for other applications such as [[sleep apnoea]].&amp;lt;ref name=&amp;quot;pmid8776785&amp;quot;&amp;gt;{{cite journal | vauthors = Hedner J, Grunstein R, Eriksson B, Ejnell H | title = A double-blind, randomized trial of sabeluzole--a putative glutamate antagonist--in obstructive sleep apnea | journal = Sleep | volume = 19 | issue = 4 | pages = 287–9 | date = May 1996 | pmid = 8776785 | doi = 10.1093/sleep/19.4.287 | doi-access =  }}&amp;lt;/ref&amp;gt; It acts primarily as an [[NMDA antagonist]],&amp;lt;ref name=&amp;quot;pmid8458392&amp;quot;&amp;gt;{{cite journal | vauthors = Van der Valk JB, Vijverberg HP | title = Chronic sabeluzole treatment of cultured rat cerebellar granule cells reduces N-methyl-D-aspartate-induced inward current | journal = European Journal of Pharmacology | volume = 232 | issue = 1 | pages = 131–4 | date = February 1993 | pmid = 8458392 | doi = 10.1016/0014-2999(93)90738-4 }}&amp;lt;/ref&amp;gt; but other [[mechanisms of action]] may also be important.&amp;lt;ref name=&amp;quot;pmid8832632&amp;quot;&amp;gt;{{cite journal | vauthors = Geerts H, Nuydens R, De Jong M, Cornelissen F, Nuyens R, Wouters L | title = Sabeluzole stabilizes the neuronal cytoskeleton | journal = Neurobiology of Aging | volume = 17 | issue = 4 | pages = 573–81 | year = 1996 | pmid = 8832632 | doi = 10.1016/0197-4580(96)00067-x | s2cid = 25920662 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid9131769&amp;quot;&amp;gt;{{cite journal | vauthors = Uberti D, Rizzini C, Galli P, Pizzi M, Grilli M, Lesage A, Spano P, Memo M | display-authors = 6 | title = Priming of cultured neurons with sabeluzole results in long-lasting inhibition of neurotoxin-induced tau expression and cell death | journal = Synapse | volume = 26 | issue = 2 | pages = 95–103 | date = June 1997 | pmid = 9131769 | doi = 10.1002/(SICI)1098-2396(199706)26:2&amp;lt;95::AID-SYN1&amp;gt;3.0.CO;2-8 | hdl = 11379/164175 | url = https://iris.unibs.it/bitstream/11379/164175/1/Synapse%201997.pdf | hdl-access = free }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== See also ==&lt;br /&gt;
* [[Memantine]]&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
{{Reflist}}&lt;br /&gt;
&lt;br /&gt;
{{Ionotropic glutamate receptor modulators}}&lt;br /&gt;
&lt;br /&gt;
[[Category:NMDA receptor antagonists]]&lt;br /&gt;
[[Category:4-Fluorophenyl compounds]]&lt;br /&gt;
[[Category:Phenol ethers]]&lt;br /&gt;
[[Category:Secondary alcohols]]&lt;br /&gt;
[[Category:Piperidines]]&lt;br /&gt;
[[Category:Benzothiazoles]]&lt;br /&gt;
&lt;br /&gt;
{{nervous-system-drug-stub}}&lt;/div&gt;</summary>
		<author><name>imported&gt;JWBE</name></author>
	</entry>
</feed>